Australia returns to 'war footing' amid COVID-19 vaccine turmoil | Inquirer News

Australia returns to ‘war footing’ amid COVID-19 vaccine turmoil

/ 10:40 AM April 14, 2021

Australia returns to 'war footing' amid COVID-19 vaccine turmoil

FILE PHOTO: A sign for a COVID-19 vaccination clinic is seen as high-risk workers receive the first vaccines in the state of Victoria’s rollout of the program, in Melbourne, Australia, February 22, 2021. REUTERS/Sandra Sanders

SYDNEY — Australia’s national cabinet will begin meeting twice a week from Monday, marking a return to a “war footing” in the country’s battle against the coronavirus pandemic amid turmoil in its national vaccination program.

Prime Minister Scott Morrison said on Wednesday the return to more frequent meetings of the group of federal and state government leaders was necessary to address “serious challenges” caused by patchy international vaccine supplies and changing medical advice.

Article continues after this advertisement

“This is a complex task and there are problems with the program that we need to solve to ensure more Australians can be vaccinated safely and more quickly,” Morrison said in a statement.

FEATURED STORIES

Australia has fared much better than many other developed countries during the pandemic, with just over 29,400 COVID-19 cases and 910 deaths.

No new cases have been reported on most days this year and officials have swiftly contained small outbreaks, but the country’s vaccination program has hit major roadblocks.

Article continues after this advertisement

Morrison earlier this week abandoned a target to provide at least one vaccine dose to the country’s near 26 million population by year-end after restricting the rollout of its favored AstraZeneca vaccine.

Article continues after this advertisement

Findings by Europe’s drug regulator of rare cases of blood clots among some adult recipients of the AstraZeneca vaccine were a major blow for Australia as the country had based its immunization drive largely on that inoculation, with plans to manufacture 50 million doses locally.

Article continues after this advertisement

Australian officials overhauled the program in response, doubling an earlier Pfizer order to 40 million shots and restricting AstraZeneca doses to people under 50.

The rollout has also been affected by export curbs imposed by the European Union on vaccines as the bloc seeks to shore up its own supplies.

Article continues after this advertisement

Trade Minister Dan Tehan is due to travel to Europe this week to seek the release of about 3 million doses of previously promised AstraZeneca vaccines.

Morrison created a national cabinet of federal, state and territory leaders early last year to coordinate measures to combat the pandemic. There has been sniping in recent weeks between different levels of government about who is responsible for delays in the vaccine rollout.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The return to twice weekly meetings, the same frequency as at the peak of the crisis last year, would continue for the “foreseeable future”, Morrison said, without providing detail on any potential steps to be taken.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Australia, COVID-19

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.